A seven-year-old boy with fever, lymphadenopathy, hepatosplenomegaly, and prominent eosinophilia

New England Journal of Medicine

Volumn 335, Issue 8, 1996, Pages 577-584

  Gorlin, I F ^a   Ferry, J A ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE;

ACUTE LYMPHOCYTIC LEUKEMIA; ARTICLE; BONE MARROW BIOPSY; CASE REPORT; CHILD; DIFFERENTIAL DIAGNOSIS; DRUG HYPERSENSITIVITY; EOSINOPHILIA; HEPATOSPLENOMEGALY; HUMAN; LYMPHADENOPATHY; MALE; PRIORITY JOURNAL; SEIZURE;

EID: 9444233905     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199608223350808     Document Type: Article

References (36)

1. Anderson DC, Smith CW, Mahoney DH. Quantitative and functional disorders of granulocytes. In: Oski FA, DeAngelis CD, Feigin RD, Warshaw JB, eds. Principles and practice of pediatrics. Philadelphia: J.B. Lippincott, 1990:1526-40.
2. Boyce JA, Friend D, Gurish MF, Austen KF, Owen WF. Constitutive production of granulocyte/macrophage colony-stimulating factor by hypodense mononuclear eosinophils developed in vitro from hybrid eosinophil/basophil granulocytes. Proc Natl Acad Sci U S A 1996;93:2436-41.
3. Weller PF. Eosinophils and allergic diseases: structure, function, and clinical considerations. In: Bloch K, Geha R, eds. Intensive review of adult and pediatric allergy and immunology. Boston: American Academy of Allergy and Immunology, 1995:597-600.
4. Dent LA, Strath M, Mellor AL, Sanderson CJ. Eosinophilia in transgenic mice expressing interleukin 5. J Exp Med 1990;172:1425-31.
5. O'Shaughnessy JA, Venzon DJ, Gossard M, et al. A phase I study of sequential versus concurrent interleukin-3 and granulocyte-macrophage colony-stimulating factor in advanced breast cancer patients treated with FLAG (5-fluorouracil, leucovorin, doxorubicin, cyclophosphamide) chemotherapy. Blood 1995;86:2913-21.
6. Boyce JA. Biology of eosinophils. In: Sheffer AL, Bloch K, Geha RS, eds. Intensive review of adult and pediatric allergy and immunology. Milwaukee: American Academy of Allergy and Immunology, 1995:589-94.
7. Roujeau JC, Stern RS. Severe adverse cutaneous reactions to drugs. N Engl J Med 1994;331:1272-85.
8. Kilbourne EM, de la Paz MP, Borda IA, Ruiz-Navarro MD, Philen RM, Falk H. Toxic oil syndrome: a current clinical and epidemiologic summary, including comparisons with the eosinophilia-myalgia syndrome. J Am Coll Cardiol 1991;18:711-7.
9. Wang CH, Gao SF, Guo YP Diagnostic significance of eosinophilia of the cerebrospinal fluid in cerebral cysticercosis. Chinese Med J 1993;106:282-4.
10. Toxocariasis (visceral larva migrans; ocular larva migrans.) In: 1994 Red book: report of the Committee on Infectious Diseases. 23rd ed. Evanston, Ill.: American Academy of Pediatrics, 1994:469-70.
11. Perlmutter AD, Edlow JB, Kevy SV. Toxocara antibodies in eosinophilic cystitis. J Pediatr 1968;73:340-4.
12. Khin-Maung U, Aung-Than B. House-dust mite allergy and eosinophilia in patients with asthma in Rangoon. J Asthma 1992;29:383-91.
13. Slungaard A, Ascensao J, Zanjani E, Jacob HS. Pulmonary carcinoma with cosinophilia: demonstration of a tumor-derived eosinophilopoietic factor. N Engl J Med 1983;309:778-81.
14. Rothenberg ME, Luster AD, Leder P. Murine eotaxin: an eosinophil chemoattractant inducible in endothelial cells and in interleukin 4-induced tumor suppression. Proc Natl Acad Sci U S A 1995;92:8960-4.
15. Pretlow TP, Keith EF, Cryar AK, et al. Eosinophil infiltration of human colonic carcinomas as a prognostic indicator. Cancer Res 1983;43:2997-3000.
16. Tepper RI, Pattengale PK, Leder P. Murine interleukin-4 displays potent anti-tumor activity in vivo. Cell 1989;57:503-12.
17. Tepper RJ, Coffman RL, Leder P. An eosinophil-dependent mechanism for the antitumor effect of interleukin-4. Science 1992;257:548-51.
18. Champlin R, Gale RP Acute lymphoblastic leukemia: recent advances in biology and therapy. Blood 1989;73:2051-66.
19. Golub TR, Barker GF, Lovett M, Gilliland DG. Fusion of PDGF receptor β to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation. Cell 1994;77:307-16.
20. Wlodarska I, Mecucci C, Marynen P, et al. TEL gene is involved in myelodysplastic syndromes with either the typical t(95;12)(q33;p13) translocation or its variant t(10;12)(q24;p13). Blood 1995;85:2848-52.
21. Samoszuk M, Nansen L. Detection of interleukin-5 messenger RNA in Reed-Sternberg cells of Hodgkin's disease with eosinophilia. Blood 1990;75:13-6.
22. Inhorn RC, Aster JC, Roach SA, et al. A syndrome of lymphoblastic lymphoma, eosinophilia, and myeloid hyperplasia/malignancy associated with t(8;13)(p11;q11): description of a distinctive clinicopathologic entity. Blood 1995;85:1881-7
23. Adriaansen HJ, te Boekhorst PA, Hagemeijer AM, van der Schoot CE, Delwel HR, van Dongen JJ. Acute myeloid leukemia M4 with bone marrow eosinophilia (M4Eo) and inv(16)(p13q22) exhibits a specific immunophenotype with CD2 expression. Blood 1993;81:3043-51.
24. Hogan TF, Koss W, Murgo AJ, Amato RS, Fontana JA, VanScoy FL. Acute lymphoblastic leukemia with chromosomal 5:14 translocation and hypercosinophilia: case report and literature review. J Clin Oncol 1987;5: 382-90.
25. Tono-oka T, Sato Y, Matsumoto T, et al. Hypereosinophilic syndrome in acute lymphoblastic leukemia with a chromosome translocation [t(5q; 14q)]. Med Pediatr Oncol 1984;12:33-7.
26. Troxell ML, Mills GM, Allen RC. The hypereosinophilic syndrome in acute lymphocytic leukemia. Cancer 1984;54:1058-61.
27. Grimaldi JC, Meeker TC. The t(5;14) chromosomal translocation in a case of acute lymphocytic leukemia joins the interleukin-3 gene to the immunoglobulin heavy chain gene. Blood 1989;73:2081-5.
28. Meeker TC, Hardy D, Willman C, Hogan T, Abrams J. Activation of the interleukin-3 gene by chromosome translocation in acute lymphocytic leukemia with eosinophilia. Blood 1990;76:285-9.
29. Schiff DE, Ortega JA. Chorea, eosinophilia, and lupus anticoagulant associated with acute lymphoblastic leukemia. Pediatr Neurol 1992;8:466-8.
30. Bajaj SP, Rapaport SI, Fierer DS, Herbst KD, Schwartz DB. A mechanism for the hypoprothrombinemia of the acquired hypoprothrombinemia-lupus anticoagulant syndrome. Blood 1983;61:684-92.
31. Fleck RA, Rapaport SI, Vijaya M, Rao LV. Anti-prothrombin antibodies and the lupus anticoagulant. Blood 1988;72:512-9.
32. Lewis IJ, Rosenbloom L. Glandular fever-like syndrome, pulmonary cosinophilia and asthma associated with carbamazepine. Postgrad Med J 1982;58:100-1.
33. Yates P, Stockdill G, McIntyre M. Hypersensitivity to carbamazepine presenting as pseudolymphoma. J Clin Pathol 1986;39:1224-8.
34. Cullinan SA, Bower GC. Acute pulmonary hypersensitivity to carbamazepine. Chest 1975;68:580-1.
35. De Vriese AS, Philippe J, Van Renterghem DM, et al. Carbamazepine hypersensitivity syndrome: report of 4 cases and review of the literature. Medicine (Baltimore) 1995;74:144-51.
36. Harris DWS, Ostlere L, Buckley C, Whittaker S, Sweny P, Austin MH. Phenytoin-induced pseudolymphoma: a report of a case and review of the literature. Br J Dermatol 1992;127:403-6.